Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms [11C]YL 9, [11C]YL9 |
Target |
Action modulators |
Mechanism BET modulators(Bromodomain and extra terminal domain protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | United States | 21 Mar 2025 |